1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics in the United States, November 2019

Healthcare Analysis & Statistics in the United States, November 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

Publication dates

Publishers

All regions

1-30 of about 13000 reports

World Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

World Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

  • $ 19500
  • Industry report
  • September 2019

World Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and InstrumentationThe ...

  • Industries : Pathology
  • Countries : Europe, United States, Japan, World
Global Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Global Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 19500
  • Industry report
  • September 2019

Global Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewSummaryThis ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics
  • Countries : United States, World, Japan, Europe
Global Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Global Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 19500
  • Industry report
  • August 2019

Global Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation ...

  • Industries : Pathology
  • Countries : Japan, World, United States, Europe
Transfusion Diagnostics Market: Immunohematology and NAT Testing--US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging Opportunities

Transfusion Diagnostics Market: Immunohematology and NAT Testing--US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging Opportunities

  • $ 18500
  • Industry report
  • November 2019

Transfusion Diagnostics Market: Immunohematology and NAT Testing--US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ...

  • Industries : Diagnostics
  • Countries : United States, Europe, Japan
Global Automated Microbiology Market for over 100 Tests

Global Automated Microbiology Market for over 100 Tests

  • $ 18500
  • Industry report
  • September 2019

Global Automated Microbiology Market for over 100 Tests: US, Europe, JapanLeadingMarketResearch.com's new report is a seven-country strategic analysis of the major business opportunities emerging ...

  • Industries : Pathology
  • Countries : World, United States, Japan
Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 18500
  • Industry report
  • September 2019

Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewThis new report ...

  • Industries : Pathology
  • Countries : Japan, World, United States, Europe
Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

  • $ 14500
  • Industry report
  • October 2019

Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, ...

  • Industries : Diagnostics
  • Countries : Japan, United States, World, Europe
Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities

Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities

  • $ 14500
  • Industry report
  • October 2019

Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, ...

  • Industries : Diagnostics
  • Countries : Japan, United States, World, Europe
Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 14500
  • Industry report
  • August 2019

Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewSummaryThis ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics
  • Countries : United States, Japan, Europe, World
Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

  • $ 12500
  • Industry report
  • November 2019

Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation ...

  • Industries : Diagnostics
  • Countries : World, United States, Europe, Japan
Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • October 2019

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028SummaryAxial spondyloarthritis (axSpA) is a disease group encompassing both ankylosing spondylitis (AS) and non-radiographic axial ...

  • Industries : Medical Biotechnology, Pharmaceutical, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, World
Female Infertility: Opportunity Analysis and Forecasts to 2028

Female Infertility: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • September 2019

Female Infertility: Opportunity Analysis and Forecasts to 2028SummaryThe report “Female Infertility: Opportunity Analysis and Forecasts to 2028” expects the Female Infertility (FI) drug market to grow ...

  • Industries : Therapy, Pathology, Healthcare, Pharmaceutical
  • Countries : United States
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • September 2019

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028SummaryThe latest report “Ovarian Cancer: Opportunity Analysis and Forecasts to 2028” values the Ovarian Cancer market at $1.8bn in 2018 across ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World, Japan
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • August 2019

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028SummaryHemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively.Patients ...

  • Industries : Pathology, Healthcare
  • Countries : United States, World, China, East Asia, North America, Japan
Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • August 2019

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028SummaryThe prostate cancer market will undergo a moderate increase at a compound annual growth rate (CAGR) of 3.3% from an estimated $9.3bn ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States, East Asia, Japan, China, World, North America
Alopecia Areata: Opportunity Analysis and Forecasts to 2028

Alopecia Areata: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • August 2019

Alopecia Areata: Opportunity Analysis and Forecasts to 2028SummaryAlopecia areata (AA) is the second most common non-scarring alopecia and there are no clear reasons for the onset of the condition; however, ...

  • Industries : Pathology, Therapy
  • Countries : United States
Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028

Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • August 2019

Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028SummaryAllergic rhinitis (AR) is a common, IgE-mediated inflammatory disease in which an individual reacts to an otherwise innocuous ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical, Chronic Disease, Pathology
  • Countries : United States, Japan, World, East Asia, North America
Cyramza

Cyramza

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCyramza (ramucirumab; Eli Lilly) is a fully human vascular endothelial growth factor receptor (VEGFR)-2-directed immunoglobulin G1 monoclonal antibody that binds to the extracellular domain ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Nexavar

Nexavar

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewNexavar (sorafenib; Bayer/Amgen) is an orally available, multi-targeted tyrosine kinase inhibitor that is directed against several targets, including CRAF, BRAF, RET, KIT, FMS-like tyrosine ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, Japan, European Union
Tecentriq

Tecentriq

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTecentriq (atezolizumab; Roche/Chugai) is a fully humanized monoclonal antibody that targets programmed death-ligand 1 (PD-L1). PD-L1 is expressed on the surface of antigen-presenting cells ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union
Opdivo

Opdivo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewOpdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) is a fully human immunoglobulin G4 PD-1 immune checkpoint inhibitor that binds to the checkpoint receptor PD-1 expressed on activated ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union, Japan
tislelizumab

tislelizumab

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTislelizumab (BeiGene) is a humanized monoclonal antibody that was designed to bind to the PD-1 receptor and prevent binding of PD-L1. In addition, tislelizumab was designed to minimize binding ...

  • Industries : Pathology, Medical Biotechnology
  • Countries : United States
Lenvima

Lenvima

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewLenvima (lenvatinib; Eisai/Merck and Co) is an orally available small molecule inhibitor of multiple tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR), platelet-derived ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Keytruda

Keytruda

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewKeytruda (pembrolizumab; Merck and Co) is a humanized monoclonal antibody designed to inhibit the PD-1 co-inhibitory receptor. The interaction between PD-1 and its primary ligand, PD-L1, inhibits ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Stivarga

Stivarga

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewStivarga (regorafenib; Bayer/Amgen) is an orally available small molecule inhibitor that is currently approved for the treatment of previously treated hepatocellular carcinoma patients. It ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Cabometyx

Cabometyx

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCabometyx (cabozantinib; Exelixis/Ipsen/Takeda) is an orally available small molecule inhibitor which has been shown to suppress tumor growth and metastasis by inhibiting the activity of multiple ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Imfinzi

Imfinzi

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewImfinzi (durvalumab; AstraZeneca) is a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1). The interaction between PD-L1 and its receptor, programmed death-1 (PD-1), ...

  • Industries : Pathology, Cancer
  • Countries : European Union, Japan, United States
Menveo

Menveo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewMenveo (quadrivalent oligosaccharide diphtheria CRM-197 conjugate vaccine; GlaxoSmithKline) is a quadrivalent meningococcal glycoconjugate vaccine that uses CRM-197, a natural mutant of the ...

  • Industries : Therapy, Pathology
  • Countries : United States, European Union
Menactra

Menactra

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewMenactra (Sanofi) is a quadrivalent polysaccharide diphtheria toxoid conjugate vaccine indicated for active immunization to prevent invasive meningococcal disease (IMD) caused by Neisseria ...

  • Industries : Therapy, Pathology
  • Countries : United States
Trumenba

Trumenba

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTrumenba (Pfizer) is a bivalent recombinant meningococcal serogroup B vaccine indicated for immunization to prevent invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup ...

  • Industries : Pathology
  • Countries : United States

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on